AzTrials
AzTrials

Osteo Arthritis KneeNCT03924128

Study of the Effects of Photobiomodulation in Patients With Osteoarthritis

A study testing Photobiomodulation in people with Osteo Arthritis Knee and Pain, Chronic, run by University of Sao Paulo at 1 site in Brazil.

No Longer Available

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

PhotoBioModulation (PBM) is a mature science with therapeutic efficacy in humans and animals, and with excellent results in different medical specialties without side effects. However there are gaps that prevent adoption on a large scale. Read more about this study

Who is it for?
Ages 21 years and olderHealthy volunteers can take part
Conditions the study is for
Osteo Arthritis Knee, Pain, Chronic, Inflammation
What is being tested?
Photobiomodulation
Type of treatment
Medical device
How many people
Not given
Where
1 siteBrazil
Study dates
Start not givento not given
Phase
Expanded access
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 21 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Male and female subjects age ≥ 20 years old
  • Diagnosed with Osteoarthritis stages III and IV according to the American College of Rheumatology
  • Pain
  • Functional impairment for more than 3 months, able to wander with or without canes.

Who cannot join

  • History of cancer
  • Unstable cardiovascular disease
  • uncontrolled hypertension
  • morbid obesity, that is, BMI ≥ 40
  • terminal illness
  • cerebrovascular disease
Show all 9Show fewer
  • dementia
  • heart pacemaker
  • superior or inferior limb fractures.

Trial locations and contacts

1 site in 1 country.

Brazil1 site
  • University of Sao Paulo

    São Paulo, São Paulo, 05508-000

Other trials in Brazil

About this study

PhotoBioModulation (PBM) is a mature science with therapeutic efficacy in humans and animals, and with excellent results in different medical specialties without side effects. However there are gaps that prevent adoption on a large scale. Recent research developed by our group and partners allowed us to understand the mechanisms of action of PBM, from Molecular Physics through Biochemistry and with consequent clinical validation, with precise, replicable and personalized therapeutic results. These findings have led to treatments for many kinds of pains with industrial predictability and accuracy, phenotypic adequacy technologies that are encapsulated, prescribed, and applied. Photobiomodulation applications cover treatments for pain, inflammation, tissue regeneration, healing, immune system activation, all of which are essential characteristics for osteoarthritis therapy. Our idea is to formulate great challenges of Photobiomodulation as a solution to osteoarthritis as follows: 1) Make PBM-based therapies as predictable as drug-based therapies; this is possible with precise dose calculation performed by our team; 2) Map the biochemical and molecular effects of PBM, including those related to gene expression; 3) Unify PBM theory by synthesizing and giving meaning to the millions of PBM data associated with osteoarthritis and correlating with clinical study to be performed under this thematic project. Overcoming these challenges, PBM will become a complementary (or supplementary) alternative to medications, physiotherapy and surgical procedures for the treatment of osteoarthritis.

Read the detailed description

Treatment Procedure Treatment was administered twice a week on the same days over a period of 5 weeks with the system Light-Aid (Bright Photomedicine, SP, Brazil), operated at continuous wave, with 100 LED of 850 nm wavelength) or with a placebo probe of same appearance and display. The irradiation parameters were customized based on the disease, pain intensity, skin phototype and BMI. The probes were numbered A (active) and B (placebo). Treatment was administered in contact to the skin over the patient's knee. Both knees were treated but statistical analysis was done only for the worst one.

Knee Pain scores Visual analogue scale (VAS) was used to evaluate pain. Patients were instructed to number their level of pain from 0 (absence of pain) to 10 (worst possible pain). The VAS was applied after each PBMT session, and weekly for sixteen weeks after treatment Quality of life Two Quality of Life (QOL) questionnaires were used: Knee injury and Osteoarthritis Outcome Score (KOOS) and World Health Organization Quality of Life-bref (WHOQOL-abbreviated). Both evaluations were recorded and compared before and after the last session of treatment.

The KOOS evaluate both short-term and long-term consequences of knee injury and OA. It holds 42 items in 5 separately scored subscales; Pain, other Symptoms, Function in daily living (ADL), Function in Sport and Recreation (Sport/Rec), and knee-related QOL. Scores are transformed to a 0-100 scale, with zero representing extreme knee problems and 100 representing no knee problems as common in orthopedic scales and generic measures. Scores between 0 and 100 represent the percentage of total possible score achieved.

The WHOQOL assesses the individual's perceptions in the context of their culture and value systems, and their personal goals, standards and concerns. The WHOQOL-BREF instrument comprises 26 items, which measure the following broad domains: physical health, psychological health, social relationships, and environment.

Physical Function For functional assessments, the timed up and go test (TUG) and the sit-to-stand test (STS) were used. TUG determines fall risk and measures the progress of balance, sit to stand and walking. STS test is a method for lower extremity strength assessment. Both evaluations were recorded and compared before and after the last treatment session and the details of it can be found in supplementary material.

For the TUG and STS, patients were instructed to initiate the test at a sitting position, with the trunk in an erect posture, arms crossed over the chest, and feet on the floor. TUG is a mobility test that evaluates the time that the patient takes to get up from a chair, walk a distance of 3 m at a normal speed until he/she reaches a mark on the ground, then turn around, walk back and sit on the chair without the support of the arms. Patients were instructed to perform the sit-to-stand movements as fast as possible in 30 seconds. The number of completed sit-to-stands in 30 seconds was recorded.

Being tested
Photobiomodulation
Medical subject headings
Chronic Pain, Inflammation

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • PhotobiomodulationDevice

    The Photobiomodulation device should cover the entire knee junction, with time of application from 6 to 8 minutes and device turned on.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted23 Apr 2019

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Expanded access
IDs, dates and publications
ClinicalTrials.gov ID
NCT03924128
Sponsor's protocol ID
93744418.5.0000.0068
Status last verified
Oct 2022
First submitted
17 Apr 2019
Last updated
4 Nov 2022
Results posted
No

Questions about this trial

What is this clinical trial studying?

A study testing Photobiomodulation in people with Osteo Arthritis Knee and Pain, Chronic, run by University of Sao Paulo at 1 site in Brazil.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 4 Nov 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Brazil. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Nov 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in